-
Sector Analysis
Middle East and Africa (MEA) Hydrogen Market Size and Analysis by Application Areas, Upcoming Projects, Policies and Key Players to 2030
Middle East and Africa (MEA) Hydrogen Market Report Overview The active hydrogen capacity in the MEA stood at 0.21 mtpa as of February 2024. The MEA region is emerging as a key player within the emerging hydrogen market. The region has several large-scale low-carbon hydrogen projects in the pipeline that will boost its positioning within the global hydrogen market. Many African countries will be key contributors to the MEA’s emerging hydrogen market including Egypt, Mauritania, Morocco, and South Africa as...
-
Thematic Analysis
Packaging M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Packaging Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Oropharyngeal Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...
-
Product Insights
NewAnal Cancer – Drugs In Development, 2024
Empower your strategies with our Anal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, and narrowing of stool. Predisposing factors include HPV infections, smoking, and lowered immunity. The Anal Cancer drugs in development market research report provide comprehensive information on the therapeutics under development for Anal...
-
Product Insights
NewHypopharyngeal Cancer – Drugs In Development, 2024
Empower your strategies with our Hypopharyngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Hypopharyngeal cancer is a term used for tumors of a subsite of the upper aerodigestive tract, and like most other subsite designations, the distinction is anatomic rather than pathophysiologic within the group of head and neck malignancies. The hypopharynx is the region between the oropharynx above (at the level of the hyoid bone) and the esophageal inlet below (at the lower end...
-
Product Insights
NewRectal Cancer – Drugs In Development, 2024
Empower your strategies with our Rectal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources, and personal or family history of polyps or colorectal cancer. Rectal cancer commonly spreads to organs such as...
-
Product Insights
NewLaryngeal Cancer – Drugs In Development, 2024
Empower your strategies with our Laryngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Laryngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the larynx. Most laryngeal cancers form in squamous cells, the thin, flat cells lining the inside of the larynx. Symptoms include persistent hoarseness, difficulty swallowing, sore throat, or a lump in the neck. Treatment involves a combination of surgery, radiation therapy, and chemotherapy. Early detection is crucial...
-
Product Insights
NewOropharyngeal Cancer – Drugs In Development, 2024
Empower your strategies with our Oropharyngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Oropharyngeal cancer is a disease in which malignant cells form in the tissue of oropharynx. The oropharynx is the middle part of the throat and includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. Oropharyngeal cancers can be divided into two types: HPV-positive, which are related to human papillomavirus infection; and HPV-negative cancers, which...
-
Sector Analysis
United States (US) Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
US Defense Market Report Overview The US defense budget was worth $818.8 billion in 2023, which was a 10.7% rise from the previous year. This is in response to the deteriorating global security environment such as the Russian invasion of Ukraine and continued tensions with China over territory in the South China Sea and wider Indo-Pacific. Numerous geo-strategic and domestic political imperatives continue to drive US expenditure as defense capabilities gain growing political importance. The country’s defense budget is expected to...